drugset / Trial / NCT03107975

Effect of Human Amniotic Epithelial Cells on Children With Spastic Cerebral Palsy

NCT03107975 ↗

NaSingle-groupOpen-labelTreatment

Summary

This study aimed to evaluate the therapeutic potential of human amniotic epithelial cell (hAEC) transplant in the management of children with spastic cerebral palsy.

Timeline

Start
2017-04-01
Primary completion
2017-12-31
Completion
2018-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject human amniotic epithelial cells Cell therapy — Intrathecal